Crohn’s & Colitis Congress

  • January 21, 2021 - January 24, 2021
  • Virtual Conference

Prof. Yehuda Ringel, CSO of Biomica, will present “BMC322 – A rationally-designed live bacterial consortium based on microbiome functional genomic analysis for treatment of IBD” on Saturday 23rd January, 2021 at 2PM (EST).

For details on the conference see: www.crohnscolitiscongress.org

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.